Clinical Trial Update: A Trial of Imatinib for Patients With Aggressive Desmoid Tumor (Aggressive Fibromatosis) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating imatinib for aggressive desmoid tumor (aggressive fibromatosis) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggressive Fibromatosis
• Desmoid Tumor
• Fibromatosis

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Yonsei University | Conditions: Fibromatosis | Phase 2 | Status: COMPLETED